Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chengdu Baiyu Pharmaceutical patents DNA-PK inhibitors

Nov. 5, 2021

RAPT Therapeutics patents USP7 inhibitors

Nov. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical describes HBV antivirals

Nov. 4, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Keaise Medicine patents TRXR inhibitors

Nov. 4, 2021

U.S. researchers patent new meayamycin derivatives

Nov. 3, 2021

GB005 synthesizes BTK inhibitors

Nov. 3, 2021

UCB identifies new IL-17 modulators

Nov. 3, 2021

Foghorn Therapeutics discloses new PROTACs

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...